
-
Opthea NASDAQ:OPT
Location: Se 403 L 4, 650 Chapel St, Victoria, 3141, Australia | Website: http://www.opthea.com | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
6.208B
Cash
172.5M
Avg Qtr Burn
-40.25M
Short % of Float
0.05%
Insider Ownership
0.00%
Institutional Own.
3.50%
Qtr Updated
06/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
OPT-302 Details Wet age-related macular degeneration , Eye disease | Phase 3 Data readout | |
OPT-302 Details Diabetes, Eye disease , Diabetic macular edema | Failed Discontinued |